2 ARTICLES

Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.
11 Dec 2025
Forced to buy out investors of its struggling diagnostics arm, Fortis now has the additional burden of reviving Agilus even as it’s trying to get the core healthcare business back on track.
09 Oct 2024